Having trouble reading this email? View the web version here \| Forward this email to a colleague

Dr. David-Alexandre Gros appointed Chief Strategy Officer of Sanofi

Sanofi has appointed Dr. David-Alexandre Gros as Chief Strategy Officer of Sanofi, effective September 1, 2011. He will report to Christopher A. Viehbacher, Chief Executive Officer, and will join the Group Executive Committee. His position will cover all Group business development and acquisition activities as well as strategic planning, economic evaluation of projects, strategic intelligence, and alliance management....

Read more >>

More pharmaceutical & life science news:

		Merck Millipore completes acquisition of Biotest AG’s microbiology business Merck Millipore has completed the acquisition of the microbiology business of Biotest AG...

		Positive agreement received for approval of AXANUM (low-dose ASA/esomeprazole) in Europe AstraZeneca has announced that AXANUM, a fixed dose combination of 81 mg low-dose ASA (acetylsalicylic acid) and 20 mg esomeprazole, has received positive agreement for approval in 23 European Union member countries and in Norway...

		Pfizer completes sale of Capsugel business To KKR Pfizer Inc. has completed the sale of its Capsugel business to an affiliate of Kohlberg Kravis Roberts & Co. L.P...

		Eli Lilly India and Lupin announce strategic collaboration to help fight the battle against Diabetes Collaboration to promote and distribute Lilly's Huminsulin range of products...

		U.S. FDA approves subcutaneous formulation of ORENCIA® (abatacept) ORENCIA® (abatacept) treatment for adults with moderate to severe rheumatoid arthritis (RA)...

		Pfizer provides U.S. regulatory update on Prevnar 13® The U.S. FDA issued a 90-day extension to the action date for the Company’s sBLA for use of Prevnar 13®...

		Viramune® (nevirapine) receives CHMP recommendation for approval The CHMP issued a Positive Opinion recommending the approval of Viramune® (nevirapine)...

		Biogen Idec strengthens MS ActiveSource(R) for people with Multiple Sclerosis Biogen Idec has strengthened its suite of services for people with multiple sclerosis (MS) with the addition of new resources and support programs...

		Investigational ultra-long-acting insulin degludec reduces hypoglycaemia and improves long-term control Ultra-long-acting insulin degludec, lowers blood glucose levels...

		Teva UK Limited launches generic Letrozole tablets Teva announce the launch of generic letrozole film-coated tablets...

		Abbott’s HIV Combo test detects infections earlier, to help prevent further HIV transmission Launch of Abbott’s ARCHITECT® HIV Ag/Ab Combo assay...

Events, conferences & exhibitions:

HUPO 2011
4 - 7 September 2011, Geneva, Switzerland

RNAi & miRNA Europe
8 - 9 September 2011, Munich, Germany

qPCR Europe
8 - 9 September 2011, Munich, Germany

Pharma eMarketing Congress 2011
13 - 14 September 2011, Lisbon, Portugal

MipTec 2011
20 - 22 September 2011, Basel, Switzerland

ADME, PK/TK, and Drug Metabolism in Drug Discovery and Development
20 - 22 September 2011, Dublin, Ireland

Pharma Outsourcing and Procurement Summit 2011
26 - 27 September 2011, Berlin, Germany

The Drug Development Process – From Discovery to Commercialization
28 - 30 September 2011, Dublin, Ireland

7th Annual Achieving Quality & Process Exellence in the Pharmaceutical Industry
5 - 6 October 2011, Barcelona, Spain

BioProduction 2011
19 - 20 October 2011, Berlin, Germany

The New Health is data driven. Biopharma is swimming in oceans of data, and it’s still growing exponentially. Quintiles is introducing a singular way to aggregate, harmonize and gain insights from your data. Quintiles Infosario™ is a new platform that allows you to view data from multiple sources—sites, labs, ECG, finance, HR and more—all in one place. So you can make better decisions, faster.

Learn how Quintiles can help you move from information to insights—and from insights to outcomes. Watch From Information to Insight at quintiles.com/newhealth

Company directory

Companies featured in our directory include:

- Accugenix Inc.
- Almac
- BD Diagnostics
- bioMérieux
- BMG LABTECH GmbH
- Bruker Daltonik GmbH
- CAMO Software AS
- Cisbio Bioassays
- Cellular Dynamics International, Inc.
- Colder Products Company
- Comark Instruments
- DiscoveRx Corporation
- Expo Technologies, LLC.
- Freeman Technology
- GE Analytical Instruments
- HACH LANGE GMBH
- HORIBA Scientific
- Hudson Robotics, Inc.
- IDBS
- Natoli Engineering Company, Inc.
- Peter Huber Kältemaschinenbau
- Randox Pharma Services
- Rapid Micro Biosystems
- Sapient Discovery
- Smithers Viscient
- Synbiosis
- Syngene
- TOPRA
- Waters Corporation
- Watson-Marlow Pumps Group

Add your company >>

Join European Pharmaceutical Review on LinkedIn

Follow European Pharmaceutical Review on Twitter

Like European Pharmaceutical Review on Facebook